학술논문
Hepatic Cancer: Present Scenario, Treatment Options and Nursing Management
Document Type
Disease/Disorder overview
Author
Source
Biomedical and Pharmacology Journal. March 2023, Vol. 16 Issue 1, p419, 10 p.
Subject
Language
English
ISSN
0974-6242
Abstract
Hepatic tumors In Europe, 4-17% of new cancer cases diagnosed in 2012 were liver cancers (1). In Asia, for example, a total of 582,420 incident cases were recorded in the [...]
With an expected incidence of more than 1 million cases by 2025, liver cancer remains a problem for world health. Hepatocellular carcinoma (HCC) is the most common type of liver cancer, accounting for nearly 90% of cases. Hepatitis B and C virus infection, alcohol abuse, and smoking are the main risk factors for developing HCC. Furthermore, the molecular pathogenesis of HCC linked with non-alcoholic steatohepatitis is distinct. A quarter of all HCCs have potentially treatable mutations that have not yet been implemented in clinical practice. The current hurdle in diagnosis is the requirement for molecular data that necessitates tissue or liquid biopsies. Keywords: Hepatic cancer; Hepatocellular carcinoma; Hepatoblastome; Metastases; Treatment.
With an expected incidence of more than 1 million cases by 2025, liver cancer remains a problem for world health. Hepatocellular carcinoma (HCC) is the most common type of liver cancer, accounting for nearly 90% of cases. Hepatitis B and C virus infection, alcohol abuse, and smoking are the main risk factors for developing HCC. Furthermore, the molecular pathogenesis of HCC linked with non-alcoholic steatohepatitis is distinct. A quarter of all HCCs have potentially treatable mutations that have not yet been implemented in clinical practice. The current hurdle in diagnosis is the requirement for molecular data that necessitates tissue or liquid biopsies. Keywords: Hepatic cancer; Hepatocellular carcinoma; Hepatoblastome; Metastases; Treatment.